Pioglitazone inhibits MMP-1 expression in vascular smooth muscle cells through a mitogen-activated protein kinase-independent mechanism

被引:16
作者
Game, BA
Maldonado, A
He, L
Huang, Y
机构
[1] Med Univ S Carolina, Div Endocrinol Diabet & Med Genet, Dept Med, Charleston, SC 29403 USA
[2] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA
关键词
matrix metalloproteinase; atherosclerosis; peroxisome proliferator-activated receptor; signal transcluction;
D O I
10.1016/j.atherosclerosis.2004.09.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antidiabetic drug thiazoliclinedione (TZD) also has anti-atherogenic effects. Among these effects, inhibition of smooth muscle cell (SMC) migration is considered to be essential. However, the mechanism whereby TZD inhibits SMC migration is not well understood. Since it is known that matrix metalloproteinases (MMPs) play a permissive role for SMC migration, we determined if TZD inhibits the upregulation of MMP-1 expression in SMCs by oxidized LDL (oxLDL), a potent stimulator for atherogenesis. Results showed that oxLDL markedly stimulated MNIP-1 secretion, mRNA expression, and MMP-1 promoter activity, but pioglitazone significantly inhibited the oxLDL-upregulated MMP-1 expression. In an attempt to explore the signaling mechanism by which pioglitazone inhibits the oxLDL-upregulated MMP-1 expression, we found that extracellular signal-regulated kinase (ERK) and c-Jun-N-terminal kinase (JNK) pathways were required for the oxLDL-stimulated MMP-1 expression, but pioglitazone failed to antagonize the activation of ERK and JNK by oxLDL. Finally, our AP-1 activity assay showed that pioglitazone inhibited oxLDL-stimulated c-Junactivity. Taken together, the present study indicates that pioglitazone inhibits oxLDL-stimulated MMP-1 expression in VSMCs by inhibiting c-Jun transcriptional activity through a mitogen-activated protein kinase (MAPK)-independent mechanism. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 32 条
  • [1] Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation
    Aoyagi, M
    Yamamoto, M
    Azuma, H
    Nagashima, G
    Niimi, Y
    Tamaki, M
    Hirakawa, K
    Yamamoto, K
    [J]. HISTOCHEMISTRY AND CELL BIOLOGY, 1998, 109 (02) : 97 - 102
  • [2] Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury
    Bendeck, MP
    Irvin, C
    Reidy, MA
    [J]. CIRCULATION RESEARCH, 1996, 78 (01) : 38 - 43
  • [3] Smooth muscle cell matrix metalloproteinase production is stimulated via αvβ3 integrin
    Bendeck, MP
    Irvin, C
    Reidy, M
    Smith, L
    Mulholland, D
    Horton, M
    Giachelli, CM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) : 1467 - 1472
  • [5] Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
    Borden, P
    Heller, RA
    [J]. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1997, 7 (1-2): : 159 - 178
  • [6] COLLAGEN TYPE-I AND TYPE-III, COLLAGEN CONTENT, GAGS AND MECHANICAL STRENGTH OF HUMAN ATHEROSCLEROTIC PLAQUE CAPS - SPAN-WISE VARIATIONS
    BURLEIGH, MC
    BRIGGS, AD
    LENDON, CL
    DAVIES, MJ
    BORN, GVR
    RICHARDSON, PD
    [J]. ATHEROSCLEROSIS, 1992, 96 (01) : 71 - 81
  • [7] Peroxisome proliferator-activated receptors: insight into multiple cellular functions
    Escher, P
    Wahli, W
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 448 (02) : 121 - 138
  • [8] Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype
    Geary, RL
    Wong, JM
    Rossini, A
    Schwartz, SM
    Adams, LD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (12) : 2010 - 2016
  • [9] Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells
    Goetze, S
    Kim, S
    Xi, XP
    Graf, K
    Yang, DC
    Fleck, E
    Meehan, WP
    Hsueh, WA
    Law, RE
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (05) : 749 - 757
  • [10] Peroxisome proliferator-activated receptor-γ ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration
    Goetze, S
    Kintscher, U
    Kim, S
    Meehan, WP
    Kaneshiro, K
    Collins, AR
    Fleck, E
    Hsueh, WA
    Law, RE
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (06) : 909 - 921